Bariatric-Metabolic Surgery More Effective Than Lifestyle Change for NASH Roux-en-Y bypass or sleeve gastrectomy resolved NASH without exacerbating liver fibrosis Apr 26, 2023
Weight Loss Giants Going Head-to-Head; FDA OKs Omnipod GO; GLP-1 Drugs for Wolfram? News and commentary from the endocrinology world Apr 25, 2023
New Reader for FreeStyle Libre 3; COVID Bumps Diabetes Risk; Tepezza Label Expanded News and commentary from the endocrinology world Apr 18, 2023
'Relaxed' A1c OK for Mitigating Dementia Risk in Older Diabetes Patients Keeping most readings under 9% avoided elevated dementia risk Apr 17, 2023
Common Diuretic Pauses Atherosclerosis in CKD, T2D If finerenone isn't available, try spironolactone, said researcher Apr 15, 2023
Certain Painkillers Linked to Heart Failure in Type 2 Diabetes Population-based study shows older patients with poorly controlled diabetes at particular risk Apr 10, 2023
Diabetes Patient Develops Large Blisters, Macules on Lower Leg Is infection, injury, or diabetic dermopathy responsible? Apr 10, 2023
Physicians Struggle to Help Diabetes Patients Get Tirzepatide Popular drug faces supply problems and increased demand Apr 07, 2023
Can COVID Lead to Diabetes? Early work suggests a connection, but experts say more investigation is needed Mar 29, 2023
Higher Rybelsus Doses More Effective; Insulin Cap for All? Win for GLP-1/GIP Drug News and commentary from the endocrinology world Mar 28, 2023
Reversing Prediabetes Alone Doesn't Cut Mortality Risk Reduced risk only seen in physically active patients, Taiwanese study found Mar 28, 2023
Fresh Produce Is an Increasingly Popular Prescription for Chronically Ill Patients But do these initiatives work? Mar 26, 2023
Ozempic Back on Shelves; More Positive Fezolinetant Data; Caffeine Cuts Fat? News and commentary from the endocrinology world Mar 21, 2023
Why Does Insulin Cost So Much? Big Pharma Isn't the Only Player Driving Prices Casting a light on profiteering methods of price mediators Mar 12, 2023
Are High Costs of Newer Diabetes Drugs Deterring Eligible Patients? Data show most eligible patients are not using GLP-1 receptor agonists or SGLT2 inhibitors Feb 27, 2023
Zero-Cal Sweetener Erythritol Disappoints on Cardiovascular Safety Keto-friendly food additive carries unknown long-term health effects Feb 27, 2023
Dexcom G7 CGM Covered by Medicare; T1D Off-Label Drug Use; Another Tepezza Lawsuit News and commentary from the endocrinology world Feb 21, 2023
Old Drug May Help Protect People With Diabetes Against Dementia Those with history of ischemic heart disease or stroke saw greatest protection with pioglitazone Feb 15, 2023
Does COVID Vaccine Blunt Elevated Diabetes Risk After Infection? Unvaccinated had a 78% higher risk for new-onset diabetes; no link seen among the vaccinated Feb 14, 2023
Lower Blood Pressure Better in Pregnancy With Diabetes Going even lower on blood pressure appeared to help in a secondary trial analysis Feb 13, 2023
Phthalates Exposure Tied to Higher Incidence of Type 2 Diabetes in White Women But possible selection bias may have negated this risk in women of color, researchers say Feb 08, 2023
No Visual Acuity Benefit With Early Anti-VEGF for Diabetic Retinopathy "May not be worth the risk and inconvenience to the patient," researcher says Feb 07, 2023
Can High-Dose Vitamin D Prevent Diabetes? While three trials found no net benefit, combining them yielded significant risk reduction Feb 06, 2023
ED Screening Program Picks Up Lots of Undiagnosed Diabetes Cases EHR alerts at Chicago ED flagged about three in 10 at-risk patients for HbA1c testing Jan 26, 2023
Over 1 Million Medicare Beneficiaries Will Pocket Savings From Insulin Cap Report uses 2020 claims data to estimate potential effects of IRA's $35 monthly insulin cap Jan 24, 2023
It's Complicated: Hollywood Elites Didn't Use Up Everyone's Diabetes Meds A "perfect storm" of factors led to GLP-1 agonist shortages Jan 24, 2023
Diabetes Patients Also Struggle to Access GLP-1 Agonists Patients are making substitutions, crossing state lines, stopping care because of shortages Jan 24, 2023
Diabetes Drug for Cats Now Approved in Humans Too Oral SGLT2 inhibitor bexagliflozin indicated for adults with type 2 diabetes Jan 23, 2023
Sodium Nitrite in Food, Water Tied to Type 2 Diabetes Risk Observational study serves up "new piece of evidence" for debate over additives Jan 17, 2023
Rybelsus Now OK'd in First Line; Menopause Before Transition; Novel T2D Drug Flops News and commentary from the endocrinology world Jan 17, 2023
How Many Times Do You Need to Get Out of Your Chair in an Otherwise Sedentary Day? Trial tested walking break doses to counter ill effects of prolonged sitting Jan 12, 2023
Type 2 Diabetes Patients Can Also Benefit From Fully Closed-Loop System Users spent twice as much time in target glucose range vs standard insulin therapy, study showed Jan 11, 2023
Dementia Accompanying Cardiometabolic Disease: Does It Come Down to Genetics? Twin study suggests special monitoring in some individuals Dec 29, 2022
Competitor Poised to Take on Obesity Treatment Giant Wegovy in 2023 Both Eli Lilly and Novo Nordisk scramble to rectify supply shortages Dec 28, 2022
New Hypercalcemia Guideline; Untreated Hyperparathyroidism Risky; PFAS Phase-Out News and commentary from the endocrinology world Dec 27, 2022
The Year SGLT2 Inhibitors Became Full-Fledged Heart Failure Drugs Treatment no longer limited by ejection fraction Dec 27, 2022
Glycemic Control With Insulin Barely Budged Over the Past 30 Years Rates of hyperglycemia also remained elevated for racial and ethnic minorities Dec 20, 2022
Metformin Protective Against Joint Replacement in Type 2 Diabetes Daily users saw lower risks for total knee, hip replacements Dec 19, 2022
